Ardian acquires majority in Sintetica
12 August 2019 – Ardian has acquired a majority stake in Sintetica SA, a Swiss pharmaceutical company based in Mendrisio and Couvet.
Walder Wyss has acted as legal and tax counsel to Ardian in the transaction. The Walder Wyss team was being led by Florian Gunz Niedermann (Partner, Corporate/M&A), Maurus Winzap (Partner, Tax) und Lukas Wyss (Partner, Finance) and further included Stefano Fornara (Counsel, Corporate/M&A), Christian Hagen, Martina Madonna-Quadri, Alex Domeniconi, Dario Galli (Associates, Corporate/M&A), Janine Corti, Jan Ole Luuk (Counsel, Tax), Fabienne Limacher (Managing Associate, Tax), Rafal Szala (Associate, Banking/Finance), Monique Sturny (Managing Associate, Pharma/IP), Celine Weber, Christine Leuch (Associates, Pharma/IP), Nicolas Iynedjian (Partner, Real Estate) und Marie Stenger (Associate, Real Estate).